日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genetic variations in cancer-related significantly mutated genes and lung cancer susceptibility

癌症相关显著突变基因的遗传变异与肺癌易感性

Zhang, Y; Zhang, L; Li, R; Chang, D W; Ye, Y; Minna, J D; Roth, J A; Han, B; Wu, X

miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer

miR-93介导的DAB2下调定义了肺癌中一种新的致癌通路

Du, L; Zhao, Z; Ma, X; Hsiao, T-H; Chen, Y; Young, E; Suraokar, M; Wistuba, I; Minna, J D; Pertsemlidis, A

Inflammation-related genetic variants predict toxicity following definitive radiotherapy for lung cancer

炎症相关基因变异可预测肺癌根治性放疗后的毒性反应

Pu, X; Wang, L; Chang, J Y; Hildebrandt, M A T; Ye, Y; Lu, C; Skinner, H D; Niu, N; Jenkins, G D; Komaki, R; Minna, J D; Roth, J A; Weinshilboum, R M; Wu, X

NeuroD1 regulation of migration accompanies the differential sensitivity of neuroendocrine carcinomas to TrkB inhibition

NeuroD1对细胞迁移的调控与神经内分泌癌对TrkB抑制剂的敏感性差异有关。

Osborne, J K; Larsen, J E; Gonzales, J X; Shames, D S; Sato, M; Wistuba, I I; Girard, L; Minna, J D; Cobb, M H

Smac mimetics increase cancer cell response to chemotherapeutics in a TNF-α-dependent manner

Smac 模拟物以 TNF-α 依赖的方式增强癌细胞对化疗药物的反应。

Probst, B L; Liu, L; Ramesh, V; Li, L; Sun, H; Minna, J D; Wang, L

Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer

基因组和功能分析表明,CRKL是肺癌中扩增的癌基因。

Kim, Y H; Kwei, K A; Girard, L; Salari, K; Kao, J; Pacyna-Gengelbach, M; Wang, P; Hernandez-Boussard, T; Gazdar, A F; Petersen, I; Minna, J D; Pollack, J R

Clinicopathological and therapeutic significance of CXCL12 expression in lung cancer

CXCL12表达在肺癌中的临床病理及治疗意义

Imai, H; Sunaga, N; Shimizu, Y; Kakegawa, S; Shimizu, K; Sano, T; Ishizuka, T; Oyama, T; Saito, R; Minna, J D; Mori, M

Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer

基因组分析表明,TITF1 是一种在肺癌中扩增的谱系特异性癌基因。

Kwei, K A; Kim, Y H; Girard, L; Kao, J; Pacyna-Gengelbach, M; Salari, K; Lee, J; Choi, Y-L; Sato, M; Wang, P; Hernandez-Boussard, T; Gazdar, A F; Petersen, I; Minna, J D; Pollack, J R

DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers.

DNA扩增是肺癌和其他癌症中普遍存在的癌基因激活机制

Lockwood W W, Chari R, Coe B P, Girard L, Macaulay C, Lam S, Gazdar A F, Minna J D, Lam W L

Prevalence and specificity of LKB1 genetic alterations in lung cancers

LKB1基因改变在肺癌中的流行率和特异性

Matsumoto, S; Iwakawa, R; Takahashi, K; Kohno, T; Nakanishi, Y; Matsuno, Y; Suzuki, K; Nakamoto, M; Shimizu, E; Minna, J D; Yokota, J